Related Experiment Videos
Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat
Journal of Cancer Research and Clinical Oncology
|January 1, 1987
Summary
This study reveals that altered carbohydrate metabolism, specifically a shift towards glucose utilization, occurs in preneoplastic liver lesions. Hexokinase (HK) emerges as a potential indicator for early liver carcinogenesis detection.
Area of Science:
- Hepatology
- Carcinogenesis
- Biochemistry
Background:
- Preneoplastic liver lesions are critical precursors to hepatocellular carcinoma.
- Understanding metabolic alterations in early carcinogenesis is vital for timely diagnosis and intervention.
Purpose of the Study:
- To investigate the metabolic changes associated with preneoplastic liver lesions induced by 2-acetylaminofluorene in Wistar rats.
- To identify potential biomarkers for early detection of liver carcinogenesis.
Main Methods:
- Induction of preneoplastic liver lesions using 2-acetylaminofluorene in Wistar rats.
- Histochemical analysis for adenosine-5-triphosphatase and glucose-6-phosphatase (G-6-Pase) activities.
- Immunohistochemical detection of L-type pyruvate kinase.
- Microbiochemical determination of enzyme activities (G-6-Pase, glucokinase, hexokinase) in microdissected lesions.
Main Results:
- Altered hepatic foci (AHF) and hyperplastic nodules (HN) showed decreased adenosine-5-triphosphatase and G-6-Pase activities.
- A reduction in L-type pyruvate kinase was observed in preneoplastic lesions.
- Microbiochemical analysis confirmed decreased G-6-Pase, decreased glucokinase, and increased hexokinase (HK) within AHF and HN.
- These findings indicate a metabolic shift from gluconeogenesis to glucose utilization and the pentose-phosphate pathway.
Conclusions:
- The observed metabolic alterations in preneoplastic liver lesions suggest a shift towards increased glucose utilization and nucleic acid biosynthesis.
- Hexokinase (HK) activity may serve as a valuable indicator for the early stages of liver carcinogenesis, alongside other oncofetal markers.